Literature DB >> 18603680

Clostridium perfringens enterotoxin in antibiotic-associated diarrhea.

Chetana Vaishnavi1, Sukhminderjit Kaur.   

Abstract

Clostridium perfringens type A is associated with 5-20% cases of antibiotic-associated diarrhea (AAD) even though Clostridium difficile is implicated in the most severe cases. Fecal specimens from one hundred hospitalized patients, who developed diarrhea regardless of antibiotic intake and who were negative for C. difficile toxin assay, were investigated for C. perfringens enterotoxin (CPE). Simultaneously, cultures were set up for other possible aetiological factors. Ten healthy controls were also similarly investigated. CPE was positive in 2/100 (2%) of the patients and the samples were also positive for the organism in culture. Other organisms isolated were non-toxigenic C. difficile (4%), staphylococci (6%), Candida (18%) and Klebsiella pneumoniae (1%). Stool samples from healthy controls grew mixed growth of no significance and CPE was negative in all of them. Detection of CPE is not part of routine laboratory investigation due to resource implication. Criteria for initiating investigations have to be therefore established by understanding the true burden of C. perfringens-associated AAD by further research.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18603680     DOI: 10.4103/0377-4929.41681

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  2 in total

Review 1.  Inactivation Strategies for Clostridium perfringens Spores and Vegetative Cells.

Authors:  Prabhat K Talukdar; Pathima Udompijitkul; Ashfaque Hossain; Mahfuzur R Sarker
Journal:  Appl Environ Microbiol       Date:  2016-12-15       Impact factor: 4.792

2.  Preparation and field study of combined vaccine against Clostridium perfringens type A and bovine viral diarrhea virus in camels.

Authors:  Hamed Adel Elhelw; Maha Raafat Abd El Fadeel; Elham El-Sergany; Ahmad Allam; Mohamed Karam Elbayoumy; Adel Mahrous El-Kattan; Alaa Abdel-Moneim El-Kholy
Journal:  Clin Exp Vaccine Res       Date:  2022-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.